Therefore, we speculated that these genes in eccDNA of AML might accelerate the AML progression through the effects of poor prognostic factors, including complex karyotypes, monosomal karyotypes, TP53 deletion, and TP53 mutations. The gene discussed is TP53; the disease is acute myeloid leukemia.